Inventor · disambiguated record
Ana Martin-Villalba
Also filed as: MARTIN-VILLALBA ANA
3 granted patents·5 pending applications·7 citations·filing 2000–2022
62Inventor score
Files withDEUTSCHES KREBSFORSCH2DEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES OEFFENTLICHEN RECHTS2MARTIN-VILLALBA ANA2
Top patents by PatentIndex Score
8 records- 0171US9850308B2Neutralization of CD95 activity blocks invasion of glioblastoma cells in vivoDEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES OEFFENTLICHEN RECHTS·Filed 2015·Granted Dec 26, 2017·2 cites·7 claims
- 0264US9309320B2Neutralization of CD95 activity blocks invasion of glioblastoma cells in vivoMARTIN-VILLALBA ANA·Filed 2007·Granted Apr 12, 2016·2 cites·6 claims
- 0360US7935339B2Inhibition of the CD95 ligand/receptor system for the treatment of neurological disorders and injuriesDEUTSCHES KREBSFORSCH·Filed 2004·Granted May 3, 2011·3 cites·21 claims
- 0455US2025136662A1Cd95 polypeptidesDEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES OEFFENTLICHEN RECHTS·Filed 2022·Application pending·0 cites
- 0541US2011189194A1Use of cd95 inhibitors for the treatment of inflammatory disordersDEUTSCHES KREBSFORSCH·Filed 2009·Application pending·0 cites
- 0633US2003082180A1Combination of compounds that inhibit the biological effects of tnf-alpha and cd95l in a medicamentFiled 2000·Application pending·0 cites
- 0730US2011300113A1Death Receptor CD95 Controls Neurogenesis of Adult Neural Stem Cells in Vivo and in VitroMARTIN-VILLALBA ANA·Filed 2007·Application pending·0 cites
- 0830US2004092438A1Gd3-synthesis inhibitors for treating neuropathological disordersFiled 2000·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →